We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cartridge Developed to Detect Antibiotic-Resistant Bacteria

By LabMedica International staff writers
Posted on 03 Jan 2018
A diagnostic platform that exploits the phenomenon of linear dichroism (LD) for a number of uses including the detection of antibiotic resistance in infections is being developed. More...
A key attribute of this technology is that it can measure multiple targets simultaneously in the same sample.

The technology is based on the arrangement of long, thin nanometer-sized molecules in a microfluidic chamber inside a test cartridge, which is self-contained, sterile, and holds all the reagents needed to perform a test. Scientists use a handheld external optical reader, to detect the molecules' alignment in the chamber by shining polarized light from different angles into the cartridge.

The technology was created by Linear Diagnostics Ltd (Birmingham, UK), which is a spin-off from the University of Birmingham (Birmingham, UK). Scientists can modify the molecules with detection probes that bind to targets in solution. If bacteria are present in the sample, the probes bind to various bacterial targets, changing the alignment of the attached molecules in the microfluidic flow. The attached probes can be antibodies that can recognize specific bacterial cell surface markers, for instance, or short bits of DNA including genetic sequences that recognize specific bacterial transcripts or genes that code for antibiotic resistance.

The Linear Dx's tests can be used with urine and whole blood samples, since they do not require previous sample preparation, although the scientists emphasized that the company will initially focus on urinary tract infections (UTIs). While technology such as easy, rapid dipstick tests can provide an indication of bacterial presence, they lack the information on antibiotic resistance that Linear Dx's technology can provide. It is estimated the tests run on the platform will cost around USD 20 or GBP 15.

Matthew R. Hicks, DPhil, a cofounder and chief technical officer of the company, said, “Other molecular binding techniques need multiple processing steps like washing. In contrast, our platform is a single-step process, and can be adapted to a wide range of other applications in the future, including sexually transmitted infection (STIs) and tropical diseases. The reagents that we have developed enable us to use relatively low-cost hardware to give sufficient performance for the assays that we are developing.”

Related Links:
Linear Diagnostics
University of Birmingham

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Specimen Radiography System
TrueView 200 Pro
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.